Paper20041482
Correlation of pretransplant and early post-transplant response assessment with outcomes after reduced-intensity allogeneic hematopoietic stem cell transplantation for non-Hodgkin's lymphoma.
Bishop MR and 8 others. Cancer, 2010. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. Correlation of pretransplant and early post-transplant response assessment with outcomes after reduced-intensity allogeneic hematopoietic stem cell transplantation for non-Hodgkin's lymphoma. Papers, record 20041482. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20041482
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Correlation of pretransplant and early post-transplant response assessment with outcomes after reduced-intensity allogeneic hematopoietic stem cell transplantation for non-Hodgkin's lymphoma.
- PubMed
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hematopoietic Stem Cell Transplantation | Major topic |
| Lymphoma, Non-Hodgkin | Major topic |
| Adult | |
| Aged | |
| Antineoplastic Combined Chemotherapy Protocols | |
| Clinical Trials as Topic | |
| Cyclophosphamide | |
| Disease-Free Survival | |
| Doxorubicin | |
| Etoposide | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Postoperative Period | |
| Prednisone | |
| Preoperative Period | |
| Survival Rate | |
| Transplantation Conditioning | |
| Transplantation, Autologous | |
| Treatment Outcome | |
| Vincristine |
Source PubMed
Grants8
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| Z01 BC010254 | Intramural NIH HHS | United States | Z01BC010254 | PubMed | NIH RePORTER |
| Z99 CA999999 | Intramural NIH HHS | United States | Z99CA999999 | PubMed | NIH RePORTER |
| ZIABC010698 | NIH | NIH RePORTER | |||
| ZIABC011239 | NIH | NIH RePORTER | |||
| ZIASC010288 | NIH | NIH RePORTER | |||
| ZIASC010365 | NIH | NIH RePORTER | |||
| ZIDBC010963 | NIH | NIH RePORTER | |||
| ZIDSC007202 | NIH | NIH RePORTER |
References48
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12963698 | The graft-versus-lymphoma effect: fact, fiction, or opportunity? | J Clin Oncol | 2003 | https://conductscience.org/library/papers/12963698 | PubMed |
| 2 | 1991174 | Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation. | Blood | 1991 | https://conductscience.org/library/papers/1991174 | PubMed |
| 3 | 12393626 | Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation. | Blood | 2002 | https://conductscience.org/library/papers/12393626 | PubMed |
| 4 | 5910392 | Evaluation of survival data and two new rank order statistics arising in its consideration. | Cancer Chemother Rep | 1966 | https://conductscience.org/library/papers/5910392 | PubMed |
| 5 | 12963703 | Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. | J Clin Oncol | 2003 | https://conductscience.org/library/papers/12963703 | PubMed |
| 6 | 15304395 | Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma. | Blood | 2004 | https://conductscience.org/library/papers/15304395 | PubMed |
| 7 | 15197204 | Nonmyeloablative allogeneic hematopoietic transplantation: a promising salvage therapy for patients with non-Hodgkin's lymphoma whose disease has failed a prior autologous transplantation. | J Clin Oncol | 2004 | https://conductscience.org/library/papers/15197204 | PubMed |
| 8 | 7687667 | EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma. | J Clin Oncol | 1993 | https://conductscience.org/library/papers/7687667 | PubMed |
| 9 | 17488686 | Long-term outcomes after reduced-intensity conditioning allogeneic stem cell transplantation for low-grade lymphoma: a survey by the French Society of Bone Marrow Graft Transplantation and Cellular Therapy (SFGM-TC). | Haematologica | 2007 | https://conductscience.org/library/papers/17488686 | PubMed |
| 10 | 16211312 | Minimal residual disease as the target for immunotherapy and gene therapy of cancer (review). | Oncol Rep | 2005 | https://conductscience.org/library/papers/16211312 | PubMed |
| 11 | 8049425 | Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin's lymphoma. | Blood | 1994 | https://conductscience.org/library/papers/8049425 | PubMed |
| 12 | 12446434 | Non-myeloablative transplantation. | Hematology Am Soc Hematol Educ Program | 2002 | https://conductscience.org/library/papers/12446434 | PubMed |
| 13 | 9807740 | Allogeneic cell-mediated and cytokine-activated immunotherapy for malignant lymphoma at the stage of minimal residual disease after autologous stem cell transplantation. | J Immunother | 1998 | https://conductscience.org/library/papers/9807740 | PubMed |
| 14 | 14645431 | Nonablative allogeneic stem-cell transplantation for advanced/recurrent mantle-cell lymphoma. | J Clin Oncol | 2003 | https://conductscience.org/library/papers/14645431 | PubMed |
| 15 | 3899355 | Analysis and interpretation of the comparison of survival by treatment outcome variables in cancer clinical trials. | Cancer Treat Rep | 1985 | https://conductscience.org/library/papers/3899355 | PubMed |
| 16 | 3319146 | Passive, adoptive, and active immunotherapy: a review of clinical trials in cancer. | Cancer Detect Prev Suppl | 1987 | https://conductscience.org/library/papers/3319146 | PubMed |
| 17 | 16269861 | Allogeneic cell-mediated immunotherapy at the stage of minimal residual disease following high-dose chemotherapy supported by autologous stem cell transplantation. | Acta Haematol | 2005 | https://conductscience.org/library/papers/16269861 | PubMed |
| 18 | 12692607 | An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation. | Bone Marrow Transplant | 2003 | https://conductscience.org/library/papers/12692607 | PubMed |
| 19 | 10204198 | Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. | Stat Med | 1999 | https://conductscience.org/library/papers/10204198 | PubMed |
| 20 | 18086796 | Reduced-intensity conditioning compared with conventional allogeneic stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. | J Clin Oncol | 2008 | https://conductscience.org/library/papers/18086796 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39513887 | High-Dose Chemotherapy and Autologous or Allogeneic Transplantation in Aggressive B-Cell Lymphoma-Is There Still a Role? | Cells | 2024 | https://conductscience.org/library/papers/39513887 | PubMed |
| 30826465 | Allogeneic Transplantation after Myeloablative Rituximab/BEAM ± Bortezomib for Patients with Relapsed/Refractory Lymphoid Malignancies: 5-Year Follow-Up Results. | Biol Blood Marrow Transplant | 2019 | https://conductscience.org/library/papers/30826465 | PubMed |
| 25228589 | Clinical outcomes of a novel combination of lenalidomide and rituximab followed by stem cell transplantation for relapsed/refractory aggressive B-cell non-hodgkin lymphoma. | Oncotarget | 2014 | https://conductscience.org/library/papers/25228589 | PubMed |
| 25054045 | Conditioning with treosulfan and fludarabine for patients with refractory or relapsed non-Hodgkin lymphoma. | Mol Clin Oncol | 2014 | https://conductscience.org/library/papers/25054045 | PubMed |
| 24055823 | Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation. | Blood | 2013 | https://conductscience.org/library/papers/24055823 | PubMed |
| 23006952 | Nonmyeloablative allogeneic stem cell transplantation for non-hodgkin lymphoma. | Cancer J | 2012 | https://conductscience.org/library/papers/23006952 | PubMed |
| 22312100 | Dose-adjusted EPOCH-rituximab combined with fludarabine provides an effective bridge to reduced-intensity allogeneic hematopoietic stem-cell transplantation in patients with lymphoid malignancies. | J Clin Oncol | 2012 | https://conductscience.org/library/papers/22312100 | PubMed |
| 21946246 | Current status of allogeneic transplantation for aggressive non-Hodgkin lymphoma. | Curr Opin Oncol | 2011 | https://conductscience.org/library/papers/21946246 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| KRT20 | 54474 | PubTator's text mining | https://conductscience.org/library/genes/54474 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20041482
GET https://conductscience.org/api/papers/v1/20041482/references?page=2